Pharma Investment In Internet Promotion Rises As The FDA Grapples With A Policy
This article was originally published in The Pink Sheet Daily
Drug makers spend most ePromotion dollars on video detailing sessions with physicians, SDI Health data shows.
You may also be interested in...
Advertising rules for search engines, YouTube and blogs are among the topics for the two-day meeting.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.